← FDA DRUG APPROVALS

FDA NDA · NDA020213

MIOCHOL E

acetylcholine chloride

Sponsor: BAUSCH AND LOMB

APPLICATION
NDA020213
TYPE
NDA
ORIGINAL APPROVAL
1993-09-22
LATEST ACTION
2016-06-17
ROUTE
OPHTHALMIC
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Prescription

Products

MIOCHOL-E · ReferencePrescription
ACETYLCHOLINE CHLORIDE 20MG/VIAL · FOR SOLUTION · OPHTHALMIC

Approval history

2016-06-17Manufacturing (CMC) · Supplement 14 · standardAP
2006-05-30Manufacturing (CMC) · Supplement 10 · standardLetterAP
2000-01-24Manufacturing (CMC) · Supplement 5 · standardAP
1998-04-29Manufacturing (CMC) · Supplement 4 · standardAP
1996-10-16Manufacturing (CMC) · Supplement 3 · standardAP
1996-02-29Manufacturing (CMC) · Supplement 1 · standardAP
1995-08-18Labeling · Supplement 2 · standardAP
1993-09-22Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →